JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB233545

Anti-IFITM1 antibody [EPR22620-12]

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Recombinant Monoclonal IFITM1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 6 publications.

View Alternative Names

CD225, IFI17, IFITM1, Interferon-induced transmembrane protein 1, Dispanin subfamily A member 2a, Interferon-induced protein 17, Interferon-inducible protein 9-27, Leu-13 antigen, DSPA2a

6 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)

Immunohistochemical analysis of paraffin-embedded human cerebrum tissue labeling IFITM1 with ab233545 at 1/2000 dilution, followed by Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on blood vessels of human cerebrum (PMID : 24603679). Counter stained with hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.

The section was incubated with ab233545 for 10 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunocytochemistry/ Immunofluorescence - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-IFITM1 antibody [EPR22620-12] (AB233545)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized K562 (human chronic myelogenous leukemia cell line from bone marrow) or A549 (human lung carcinoma cell line) cells labeling IFITM1 with ab233545 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous staining in K-562 cells. Negative control : A549 (PMID : 25105503). The nuclear cpounter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).

PBS only control : Use PBS instead of primary antibody, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling IFITM1 with ab233545 at 1/2000 dilution, followed by Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on lymphocytes of human tonsil is observed. Counter stained with hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.

The section was incubated with ab233545 for 10 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Flow Cytometry (Intracellular) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-IFITM1 antibody [EPR22620-12] (AB233545)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-fixed K562 (human chronic myelogenous leukemia cell line from bone marrow) (Right) or A549 (human lung carcinoma cell line) (Left) cells labeling IFITM1 with ab233545 at 1/500 (red) compared with a Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue).

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077), at 1/2000 dilution was used as the secondary antibody.

Negative control : A549 (PMID : 25105503).

Immunoprecipitation - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
  • IP

Unknown

Immunoprecipitation - Anti-IFITM1 antibody [EPR22620-12] (AB233545)

IFITM1 was immunoprecipitated from 0.35 mg of K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate with ab233545 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab233545 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.

Lane 1 : K562 whole cell lysate 10 μg (Input).
Lane 2 : ab233545 IP in K562 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab233545 in K562 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.

All lanes:

Immunoprecipitation - Anti-IFITM1 antibody [EPR22620-12] (ab233545)

Predicted band size: 13 kDa

Observed band size: 17 kDa

false

Western blot - Anti-IFITM1 antibody [EPR22620-12] (AB233545)
  • WB

Unknown

Western blot - Anti-IFITM1 antibody [EPR22620-12] (AB233545)

Blocking and dilution buffer : 5% NFDM/TBST.

The molecular weight observed is consistent with what has been described in the literature (PMID : 25105503) IFN-α induce the expression of IFITM1(PMID : 27852071).

Negative control : A549 (PMID : 25105503).

All lanes:

Western blot - Anti-IFITM1 antibody [EPR22620-12] (ab233545) at 1/2000 dilution

Lane 1:

K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate at 20 µg

Lane 2:

A549 (human lung carcinoma cell line) whole cell lysate at 20 µg

Lane 3:

Untreated HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 4:

HeLa, treated with 10ng/ml hIFN-α for 16 hours, whole cell lysate at 20 µg

Lane 5:

TF-1 (human bone marrow erythroleukemia cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 13 kDa

Observed band size: 17 kDa

false

Exposure time: 8s

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-IFITM1 antibody [EPR22620-12]

  • Carrier free

    Anti-IFITM1 antibody [EPR22620-12] - BSA and Azide free

  • 578 PE

    PE Anti-IFITM1 antibody [EPR22620-12]

  • HRP

    HRP Anti-IFITM1 antibody [EPR22620-12]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-IFITM1 antibody [EPR22620-12]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-IFITM1 antibody [EPR22620-12]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-IFITM1 antibody [EPR22620-12]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-IFITM1 antibody [EPR22620-12]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-IFITM1 antibody [EPR22620-12]

  • 660 APC

    APC Anti-IFITM1 antibody [EPR22620-12]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22620-12

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IHC-P, WB, IP, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

IFITM1 also known as Interferon-Induced Transmembrane Protein 1 has a molecular weight of approximately 14 kDa. It is a transmembrane protein that plays an important role in host defense mechanisms. IFITM1 is expressed in various tissues including the respiratory tract gastrointestinal tract and the immune system where it serves in defending against pathogenic infections. The protein is usually found on the cell membrane and becomes highly expressed in response to interferon signaling.
Biological function summary

This protein inhibits viral entry by restricting the fusion of viral membranes with host cell membranes. IFITM1 does not function alone; it is part of the IFITM family which includes IFITM2 and IFITM3 each contributing to antiviral defense. The protein is strategically positioned to prevent the spread of viruses by blocking them from entering new cells which is important for managing viral propagation.

Pathways

IFITM1 engages the innate immune response pathway responding to viral infections by acting as a barrier to viral entry. It works alongside related proteins such as IFITM2 and IFITM3 within this pathway. IFITM1 is also part of the interferon pathway where its expression is upregulated in response to interferon signals. This relationship highlights its role in the immune response acting as a frontline protector against the invasion of viruses like influenza and others.

IFITM1 has a significant role in the context of viral infections and certain cancers. It is linked to resistance to viral infections such as influenza showing its importance in antiviral defense. In cancer aberrant expression of IFITM1 is observed in various types including breast and colorectal cancers impacting tumor progression and metastasis. The relationship of IFITM1 with interferon signaling highlights potential therapeutic targets where modulating its activity could influence disease outcomes.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronaviruses (SARS-CoV and SARS-CoV-2), Marburg virus (MARV), Ebola virus (EBOV), Dengue virus (DNV), West Nile virus (WNV), human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) (PubMed : 26354436, PubMed : 33270927). Can inhibit : influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry and SARS-CoV and SARS-CoV-2 S protein-mediated viral entry. Also implicated in cell adhesion and control of cell growth and migration (PubMed : 33270927). Inhibits SARS-CoV-2 S protein-mediated syncytia formation (PubMed : 33051876). Plays a key role in the antiproliferative action of IFN-gamma either by inhibiting the ERK activation or by arresting cell growth in G1 phase in a p53-dependent manner. Acts as a positive regulator of osteoblast differentiation. In hepatocytes, IFITM proteins act in a coordinated manner to restrict HCV infection by targeting the endocytosed HCV virion for lysosomal degradation (PubMed : 26354436). IFITM2 and IFITM3 display anti-HCV activity that may complement the anti-HCV activity of IFITM1 by inhibiting the late stages of HCV entry, possibly in a coordinated manner by trapping the virion in the endosomal pathway and targeting it for degradation at the lysosome (PubMed : 26354436).
See full target information IFITM1

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

European journal of medical research 30:582 PubMed40619436

2025

IFNα-IFITM1-ERK axis in corneal epithelial cell damage: implications for dry eye disease.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjuan Peng,Siyi Li,Guiling Zhao,Suyin Peng,Yanhua Pang

Journal of virology 99:e0127724 PubMed39601593

2024

Swine RNF5 positively regulates the antiviral activity of IFITM1 by mediating the degradation of ABHD16A.

Applications

Unspecified application

Species

Unspecified reactive species

Xuemeng Shi,Lingyi Shen,Shuaiwu Chen,Mingyang Liu,Jingyi Wang,Xin Wen,Wei Liu,Lin Mao,Yunyun Ding,Li Yu,Jun Xu

The Tohoku journal of experimental medicine 264:31-39 PubMed38866531

2024

HJURP Derived from Cancer-Associated Fibroblasts Promotes Glutamine Metabolism to Induce Resistance to Doxorubicin in Ovarian Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yanfang Lan,Hao Xu,Lanying Jin

Journal of extracellular vesicles 13:e12409 PubMed38321535

2024

Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles.

Applications

Unspecified application

Species

Unspecified reactive species

Zhengsheng Chen,Lei Luo,Teng Ye,Jiacheng Zhou,Xin Niu,Ji Yuan,Ting Yuan,Dehao Fu,Haiyan Li,Qing Li,Yang Wang

Nature medicine 28:201-211 PubMed34782790

2021

Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Sarthak Sinha,Nicole L Rosin,Rohit Arora,Elodie Labit,Arzina Jaffer,Leslie Cao,Raquel Farias,Angela P Nguyen,Luiz G N de Almeida,Antoine Dufour,Amy Bromley,Braedon McDonald,Mark R Gillrie,Marvin J Fritzler,Bryan G Yipp,Jeff Biernaskie

Frontiers in immunology 12:711145 PubMed34659201

2021

Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Yang,Yaling Li,Ruiqun Qi,Lan Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com